{
 "drug": "Belladonna and Opium Suppository",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/23/2026",
 "dayN": 33,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Padagis US LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/23/2026",
   "update_type": "New",
   "initial_posting_date": "07/23/2026",
   "package_ndc": "0574-7045-12",
   "generic_name": "Belladonna and Opium Suppository",
   "contact_info": "(800) 775-2054",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "BELLADONNA AND OPIUM"
    ],
    "generic_name": [
     "ATROPA BELLADONNA AND OPIUM"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-7045",
     "0574-7040"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RECTAL"
    ],
    "substance_name": [
     "ATROPA BELLADONNA",
     "OPIUM"
    ],
    "rxcui": [
     "312104",
     "312107"
    ],
    "spl_id": [
     "7b45a1d7-c3a5-4434-a848-45638cedd6e1"
    ],
    "spl_set_id": [
     "8301e76b-134a-43d2-a7dc-c600ccf2695c"
    ],
    "package_ndc": [
     "0574-7040-12",
     "0574-7040-04",
     "0574-7045-12",
     "0574-7045-04"
    ],
    "unii": [
     "37M3MZ001L",
     "WQZ3G9PF0H"
    ]
   },
   "update_date": "07/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Suppository",
   "presentation": "Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/23/2026",
   "update_type": "New",
   "initial_posting_date": "07/23/2026",
   "package_ndc": "0574-7040-04",
   "generic_name": "Belladonna and Opium Suppository",
   "contact_info": "(800) 775-2054",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "BELLADONNA AND OPIUM"
    ],
    "generic_name": [
     "ATROPA BELLADONNA AND OPIUM"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-7040",
     "0574-7045"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RECTAL"
    ],
    "substance_name": [
     "ATROPA BELLADONNA",
     "OPIUM"
    ],
    "rxcui": [
     "312104",
     "312107"
    ],
    "spl_id": [
     "7b45a1d7-c3a5-4434-a848-45638cedd6e1"
    ],
    "spl_set_id": [
     "8301e76b-134a-43d2-a7dc-c600ccf2695c"
    ],
    "package_ndc": [
     "0574-7040-12",
     "0574-7040-04",
     "0574-7045-12",
     "0574-7045-04"
    ],
    "unii": [
     "37M3MZ001L",
     "WQZ3G9PF0H"
    ]
   },
   "update_date": "07/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Suppository",
   "presentation": "Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/23/2026",
   "update_type": "New",
   "initial_posting_date": "07/23/2026",
   "package_ndc": "0574-7045-04",
   "generic_name": "Belladonna and Opium Suppository",
   "contact_info": "(800) 775-2054",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "BELLADONNA AND OPIUM"
    ],
    "generic_name": [
     "ATROPA BELLADONNA AND OPIUM"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-7045",
     "0574-7040"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RECTAL"
    ],
    "substance_name": [
     "ATROPA BELLADONNA",
     "OPIUM"
    ],
    "rxcui": [
     "312104",
     "312107"
    ],
    "spl_id": [
     "7b45a1d7-c3a5-4434-a848-45638cedd6e1"
    ],
    "spl_set_id": [
     "8301e76b-134a-43d2-a7dc-c600ccf2695c"
    ],
    "package_ndc": [
     "0574-7040-12",
     "0574-7040-04",
     "0574-7045-12",
     "0574-7045-04"
    ],
    "unii": [
     "37M3MZ001L",
     "WQZ3G9PF0H"
    ]
   },
   "update_date": "07/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Suppository",
   "presentation": "Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/23/2026",
   "update_type": "New",
   "initial_posting_date": "07/23/2026",
   "package_ndc": "0574-7040-12",
   "generic_name": "Belladonna and Opium Suppository",
   "contact_info": "(800) 775-2054",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "BELLADONNA AND OPIUM"
    ],
    "generic_name": [
     "ATROPA BELLADONNA AND OPIUM"
    ],
    "manufacturer_name": [
     "Padagis US LLC"
    ],
    "product_ndc": [
     "0574-7040",
     "0574-7045"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RECTAL"
    ],
    "substance_name": [
     "ATROPA BELLADONNA",
     "OPIUM"
    ],
    "rxcui": [
     "312104",
     "312107"
    ],
    "spl_id": [
     "7b45a1d7-c3a5-4434-a848-45638cedd6e1"
    ],
    "spl_set_id": [
     "8301e76b-134a-43d2-a7dc-c600ccf2695c"
    ],
    "package_ndc": [
     "0574-7040-12",
     "0574-7040-04",
     "0574-7045-12",
     "0574-7045-04"
    ],
    "unii": [
     "37M3MZ001L",
     "WQZ3G9PF0H"
    ]
   },
   "update_date": "07/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Suppository",
   "presentation": "Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12)",
   "company_name": "Padagis US LLC",
   "status": "To Be Discontinued"
  }
 ]
}